Atlas Trials

Caduet in an Untreated Subject Population

Clinical trial NCT00332761 · COMPLETED

Trial details

NCT number
NCT00332761
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
HypertensionDyslipidemia
Start date
2006-06-01
Enrollment
220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.